A detailed history of Stamos Capital Partners, L.P. transactions in Medtronic PLC stock. As of the latest transaction made, Stamos Capital Partners, L.P. holds 56,600 shares of MDT stock, worth $4.59 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
56,600
Previous 60,610 6.62%
Holding current value
$4.59 Million
Previous $4.77 Million 6.81%
% of portfolio
1.24%
Previous 1.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.84 - $91.03 $308,128 - $365,030
-4,010 Reduced 6.62%
56,600 $5.1 Million
Q2 2024

Aug 13, 2024

BUY
$78.71 - $87.02 $25,187 - $27,846
320 Added 0.53%
60,610 $4.77 Million
Q1 2024

May 14, 2024

SELL
$82.84 - $88.09 $296,567 - $315,362
-3,580 Reduced 5.61%
60,290 $5.25 Million
Q4 2023

Feb 13, 2024

BUY
$69.43 - $83.43 $1.12 Million - $1.35 Million
16,140 Added 33.82%
63,870 $5.26 Million
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $667,216 - $771,112
8,530 Added 21.76%
47,730 $3.74 Million
Q2 2023

Aug 11, 2023

BUY
$79.47 - $91.38 $1.63 Million - $1.87 Million
20,450 Added 109.07%
39,200 $3.45 Million
Q1 2023

May 12, 2023

BUY
$76.72 - $87.58 $1.44 Million - $1.64 Million
18,750 New
18,750 $1.51 Million
Q4 2020

Feb 12, 2021

SELL
$100.57 - $117.14 $251,424 - $292,850
-2,500 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $737,476 - $905,997
-8,768 Reduced 77.81%
2,500 $229,000
Q1 2020

May 15, 2020

BUY
$72.92 - $121.3 $821,662 - $1.37 Million
11,268 New
11,268 $1.02 Million
Q1 2019

May 10, 2019

SELL
$82.45 - $93.79 $742,050 - $844,110
-9,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $772,200 - $895,410
9,000 New
9,000 $819,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Stamos Capital Partners, L.P. Portfolio

Follow Stamos Capital Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Stamos Capital Partners, L.P. with notifications on news.